These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
562 related items for PubMed ID: 18268392
1. Treatment of atopic dermatitis with a combination of allergen-specific immunotherapy and a histamine-immunoglobulin complex. Nahm DH, Lee ES, Park HJ, Kim HA, Choi GS, Jeon SY. Int Arch Allergy Immunol; 2008; 146(3):235-40. PubMed ID: 18268392 [Abstract] [Full Text] [Related]
2. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Werfel T, Breuer K, Ruéff F, Przybilla B, Worm M, Grewe M, Ruzicka T, Brehler R, Wolf H, Schnitker J, Kapp A. Allergy; 2006 Feb; 61(2):202-5. PubMed ID: 16409197 [Abstract] [Full Text] [Related]
6. Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study. Cadario G, Galluccio AG, Pezza M, Appino A, Milani M, Pecora S, Mastrandrea F. Curr Med Res Opin; 2007 Oct; 23(10):2503-6. PubMed ID: 17784996 [Abstract] [Full Text] [Related]
10. House dust mites on skin, clothes, and bedding of atopic dermatitis patients. Teplitsky V, Mumcuoglu KY, Babai I, Dalal I, Cohen R, Tanay A. Int J Dermatol; 2008 Aug; 47(8):790-5. PubMed ID: 18717857 [Abstract] [Full Text] [Related]
11. The effect of local nasal immunotherapy in allergic rhinitis: using strips of the allergen dermatophagoides pteronyssinus. Tsai JJ, Liao EC, Tsai FH, Hsieh CC, Lee MF. J Asthma; 2009 Mar; 46(2):165-70. PubMed ID: 19253124 [Abstract] [Full Text] [Related]
12. [The efficacy of long-term specific immunotherapy for Dermatophagoides pteronyssinus in patients with atopic dermatitis]. Pacor ML, Biasi D, Maleknia T. Recenti Prog Med; 1994 May; 85(5):273-7. PubMed ID: 8023005 [Abstract] [Full Text] [Related]
13. [Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis. Part I. Evaluation of clinical score]. Silny W, Czarnecka-Operacz M, Silny P. Wiad Lek; 2005 May; 58(1-2):47-55. PubMed ID: 15991553 [Abstract] [Full Text] [Related]
14. [Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis Part II. Evaluation of skin reactivity and concentration of serum antigen specific immunoglobulin E directed against selected airborne allergens]. Silny W, Czarnecka-Operacz M, Silny P. Wiad Lek; 2005 May; 58(3-4):184-92. PubMed ID: 16119162 [Abstract] [Full Text] [Related]
16. [Serum eosinophil cationic protein (ECP) in patients with perennial rhinitis and atopic dermatitis, allergic to house dust mites]. Damps-Konstańska I, Gruchała-Niedoszytko M, Wilkowska A, Glén J, Konstański Z, Jassem E, Słomiński JM. Pol Merkur Lekarski; 2005 Dec; 19(114):765-8. PubMed ID: 16521419 [Abstract] [Full Text] [Related]
18. [Current trends in the specific immunotherapy for allergic syndromes due to Dermatophagoides pteronyssinus]. Pacor ML, Biasi D. Recenti Prog Med; 1994 May; 85(5):285-8. PubMed ID: 8023008 [Abstract] [Full Text] [Related]
19. Use of a specific oral hyposensitization therapy to Dermatophagoides pteronyssinus in children with atopic dermatitis. Galli E, Chini L, Nardi S, Benincori N, Panei P, Fraioli G, Moschese V, Rossi P. Allergol Immunopathol (Madr); 1994 May; 22(1):18-22. PubMed ID: 8030579 [Abstract] [Full Text] [Related]